| |
|
|
|
Oramed Pharmaceuticals Inc.  
|
|
3.04 -0.04 (-0.01%) |
10-18 16:00 |
|
Open: |
3.05 |
Pre close: |
3.08 |
Target:
|
3.74
|
|
High: |
3.1 |
Low: |
2.99 |
Resistance:
|
3.21
3.37
|
|
Volume: |
45,171 |
Market Cap: |
53M |
Support:
|
2.94
2.45
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.09
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
3.13 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
3.32  |
Stochastic Oscillator |
%K(14,3):
|
26.67 |
|
MA(250): |
3.49 |
%D(3): |
32.50 |
|
Average Volume(K) |
3-Month: |
5030
|
52-Week |
High:
|
4.69 |
|
10-Days: |
3104 |
Low: |
2.78 |
|
RSI |
RSI(14):
|
44.10 |
Change(%): |
-28.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.874 |
Return on Equity (ttm) |
-78.5 |
Shares Out. (M) |
17.38 |
|
EPS Est. Current Year |
-0.780 |
Return on Assets (ttm) |
-26.8 |
Shares Float (M) |
14.45 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
18.53 |
|
EPS Est. Next Quarter |
-0.270 |
Qtrly Rev. Growth |
10.5 |
% Held by Institutions |
22.47 |
|
Forward EPS |
-1.521 |
Gross Profit (p.s.) |
0.146 |
Shares Short (K) |
48 |
|
Book Value (p.s.) |
1.240 |
EBITDA (p.s.) |
-0.888 |
P/E |
-3.48 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.45 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.32 |
P/S |
352234656.00 |
|
Operating Margin |
-584.92 |
Levered Free Cash Flow
(M) |
-9.15 |
P/CF |
-3.69 |
|
|
|
|
|
|
